Alopecia in association with severe seborrhoeic dermatitis following combination antiretroviral therapy for acute retroviral synd ome

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 5, 2005, Pages 631-633

  Hardcastle, N J ^a,b   Tunbridge, A J ^a   Shum, K W ^a   Dockrell, D H ^a,b   Green, S T ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Alopecia; Antiretroviral therapy; Highly active; HIV; Seborrhoeic dermatitis

Indexed keywords

ANTIRETROVIRUS AGENT; BETAMETHASONE; EFAVIRENZ; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LAMIVUDINE; SHAMPOO; STAVUDINE;

ADULT; ALOPECIA; ANAMNESIS; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LABORATORY TEST; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEBORRHEIC DERMATITIS; T LYMPHOCYTE; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; ALOPECIA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BETAMETHASONE; DERMATITIS, SEBORRHEIC; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; PLANT OILS; RISK ASSESSMENT; SALICYLIC ACID; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 28544448354     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2005.01240.x     Document Type: Article

References (13)

1. Schaub NA, Drewe J, Sponagel L et al. Is there a relation between risk groups or initial CD4 T cell counts and prevalence of seborrhoeic dermatitis in HIV infected patients. J Dermatol 1999; 198: 126-129.
2. Berger RS, Stoner MF, Hobbs ER et al. Cutaneous manifestations of early human immunodeficiency virus exposure. J Am Acad Dermatol 1998; 19: 298-303.
3. Breathnach SM. Seborrhoeic dermatitis. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of Dermatology, 6th edn. Blackwell Science, Oxford, 1998: 638-643.
4. Lifson AR, Hessol NA, Buchbinder SP, Holmberg SD. The association of clinical conditions and serologic tests with CD4+ lymphocyte counts in HIV-infected subjects without AIDS. AIDS 1991; 5: 1209-1215.
5. Wikler JR, Nieboer C, Willemze R. Qualitative skin cultures of pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrhoeic dermatitis. J Am Acad Dermatol 1992; 27: 37-39.
6. Schechtman RC, Midgley G, Hay RJ. HIV disease and Malassezia yeasts: a quantitative study of patients presenting with seborrhoeic dermatitis. Br J Dermatol 1995; 133: 694-698.
7. Whiting DA, Howsden FL. Miscellaneous causes of hair loss. In: Colour Atlas of Differential Diagnosis of Hair Loss. Canfield Publishing, New Jersey, 1996: 92-94.
8. Pierard-Franchimont C, Hardcastle NJ, Tunbridge A et al. From axioms to new insights into dandruff. Dermatology 2000; 200: 93-98.
9. Fong IW. Hair loss associated with lamivudine. Lancet 1994; 344: 1702.
10. Schindler JM, Neftel KA. Simultaneous primary infection with HIV and CMV leading to severe pancytopenia, hepatitis, nephritis, perimyocarditis, myositis and alopecia totalis. Klin Wochenschr 1990; 68: 237-240.
11. Hulseboch HJ. Primary HIV-infection: infectious mononucleosis-like presentation with treatment options. Ned Tijdscr Geneesk 1999; 143: 1892-1893.
12. Connick E, Lederman MM, Kotzin BL et al. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infect Dis 2000; 181: 358-363.
13. Cheng VC, Yuen KY, Chan WM et al. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 2000; 30: 882-892.